Ligand Pharmaceuticals, Inc. (LGND)
299.00
+5.19
(+1.77%)
USD |
NASDAQ |
Nov 18, 16:00
299.00
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Price : 299.00 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 300.26 | 302.02 | 291.60 | 293.81 | 293656.0 |
| Nov 16, 2026 | 311.51 | 313.76 | 300.55 | 301.71 | 191318.0 |
| Nov 13, 2026 | 313.98 | 314.79 | 308.59 | 308.79 | 135792.0 |
| Nov 12, 2026 | 316.57 | 325.89 | 310.08 | 316.27 | 248304.0 |
| Nov 11, 2026 | 315.99 | 322.41 | 314.17 | 316.83 | 126803.0 |
| Nov 10, 2026 | 312.85 | 321.98 | 310.41 | 314.16 | 172561.0 |
| Nov 09, 2026 | 310.34 | 315.80 | 307.14 | 314.15 | 140282.0 |
| Nov 06, 2026 | 302.02 | 308.26 | 297.84 | 306.20 | 133030.0 |
| Nov 05, 2026 | 316.57 | 318.98 | 297.63 | 299.00 | 247629.0 |
| Nov 04, 2026 | 319.00 | 319.99 | 309.86 | 316.13 | 179931.0 |
| Nov 03, 2026 | 309.99 | 317.76 | 307.58 | 313.52 | 195586.0 |
| Nov 02, 2026 | 323.28 | 325.96 | 306.17 | 307.02 | 265435.0 |
| Oct 30, 2026 | 319.22 | 324.90 | 314.50 | 322.75 | 344311.0 |
| Oct 29, 2026 | 315.15 | 323.82 | 309.63 | 317.33 | 299391.0 |
| Oct 28, 2026 | 311.62 | 319.90 | 309.69 | 318.78 | 268467.0 |
| Oct 27, 2026 | 308.51 | 314.19 | 307.55 | 311.73 | 143353.0 |
| Oct 26, 2026 | 304.39 | 309.43 | 303.47 | 308.30 | 194782.0 |
| Oct 23, 2026 | 307.82 | 313.28 | 302.37 | 303.53 | 366546.0 |
| Oct 22, 2026 | 313.00 | 315.27 | 305.34 | 307.82 | 315136.0 |
| Oct 21, 2026 | 305.36 | 317.64 | 303.93 | 314.78 | 222760.0 |
| Oct 20, 2026 | 298.61 | 314.05 | 298.61 | 306.40 | 171729.0 |
| Oct 19, 2026 | 300.41 | 303.86 | 295.74 | 297.28 | 116995.0 |
| Oct 16, 2026 | 297.67 | 297.67 | 292.56 | 295.54 | 164511.0 |
| Oct 15, 2026 | 298.18 | 304.60 | 296.85 | 298.50 | 332112.0 |
| Oct 14, 2026 | 299.55 | 307.11 | 292.28 | 294.99 | 245284.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 273.98 |
| Eli Lilly & Co. | 1382.64 |
| Bristol Myers Squibb Co. | 59.57 |
| Xeris Biopharma Holdings, Inc. | 16.99 |
| LENZ Therapeutics, Inc. | 3.20 |
Price Related Metrics
| PE Ratio | 133.38 |
| PS Ratio | 24.39 |
| PEG Ratio | 16.89 |
| Price to Book Value | 6.218 |
| Price to Free Cash Flow | 107.71 |
| Earnings Yield | 0.75% |
| Market Cap | 5.980B |
| PEGY Ratio | 16.89 |
| Operating PE Ratio | 169.57 |
| Normalized PE Ratio | 80.74 |